Literature DB >> 7564227

Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a national survey.

S Yannicelli1, A Ryan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7564227     DOI： 10.1007/BF00711747

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  9 in total

1.  The use of a low phenylalanine diet with amino acid supplement in the treatment of behavioural problems in a severely mentally retarded adult female with phenylketonuria.

Authors:  R G Hoskin; T Sasitharan; R Howard
Journal:  J Intellect Disabil Res       Date:  1992-04

2.  Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria.

Authors:  H C Lou; C Lykkelund; A M Gerdes; H Udesen; P Bruhn
Journal:  Acta Paediatr Scand       Date:  1987-07

3.  Iatrogenic skin lesions in phenylketonuric children due to a low tyrosine intake.

Authors:  B François; M Diels; M de la Brassinne
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Effects of diet and behavior therapy on social and motor behavior of retarded phenylketonuric adults: an experimental analysis.

Authors:  D Marholin; R E Pohl; R M Stewart; P E Touchette; N M Townsend; E H Kolodny
Journal:  Pediatr Res       Date:  1978-03       Impact factor: 3.756

5.  Dietary treatment of adult patients with phenylketonuria.

Authors:  L Hambraeus; G Holmgren; G Samuelson
Journal:  Nutr Metab       Date:  1971       Impact factor: 4.169

6.  Physiological control of brain norepinephrine synthesis by brain tyrosine concentration.

Authors:  C J Gibson; R J Wurtman
Journal:  Life Sci       Date:  1978-04-24       Impact factor: 5.037

7.  Phenylketonuria revisited: treatment of adults with behavioural manifestations.

Authors:  R L Brunner; E H Brown; H K Berry
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

8.  Use of a restricted protein diet in the treatment of behaviour disorder in a severely mentally retarded adult female phenylketonuric patient.

Authors:  M Harper; A H Reid
Journal:  J Ment Defic Res       Date:  1987-06

9.  Effect of dietary phenylalanine restriction on visual attention span in mentally retarded subjects with phenylketonuria.

Authors:  F D Giffin; J T Clarke; D M d'Entremont
Journal:  Can J Neurol Sci       Date:  1980-05       Impact factor: 2.104
  9 in total
  9 in total

1.  Nutritional Consequences of Adhering to a Low Phenylalanine Diet for Late-Treated Adults with PKU : Low Phe Diet for Adults with PKU.

Authors:  Ingrid Wiig; Kristina Motzfeldt; Elin Bjørge Løken; Bengt Frode Kase
Journal:  JIMD Rep       Date:  2012-07-01

2.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

3.  Benefits of normalizing plasma phenylalanine: impact on behaviour and health. A case report.

Authors:  K Williams
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  A long-term study of bone mineral density in patients with phenylketonuria under diet therapy.

Authors:  Hala M Koura; Nagwa Abdallah Ismail; Ashraf F Kamel; Azza M Ahmed; Amal Saad-Hussein; Laila K Effat
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

6.  Preparation and evaluation of a novel therapeutic dairy-based drink for phenylketonuria.

Authors:  Ahmed M Abdel-Salam; Laila K Effat
Journal:  N Am J Med Sci       Date:  2010-02

7.  Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.

Authors:  Maria Giżewska; Anita MacDonald; Amaya Bélanger-Quintana; Alberto Burlina; Maureen Cleary; Turgay Coşkun; François Feillet; Ania C Muntau; Friedrich K Trefz; Francjan J van Spronsen; Nenad Blau
Journal:  Eur J Pediatr       Date:  2015-09-08       Impact factor: 3.183

Review 8.  Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.

Authors:  Deborah A Bilder; J Kay Noel; Erin R Baker; William Irish; Yinpu Chen; Markus J Merilainen; Suyash Prasad; Barbara J Winslow
Journal:  Dev Neuropsychol       Date:  2016-11-02       Impact factor: 2.253

9.  Adults with untreated phenylketonuria: out of sight, out of mind.

Authors:  Glynis H Murphy; Sally M Johnson; Allayne Amos; Eleanor Weetch; Rosemary Hoskin; Brian Fitzgerald; Maggie Lilburn; Lesley Robertson; Philip Lee
Journal:  Br J Psychiatry       Date:  2008-12       Impact factor: 9.319
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.